Molecular mimicry impact of the COVID-19 pandemic: Sequence homology between SARS-CoV-2 and autoimmune diseases epitopes, 2025, Maldonado-Catala

https://www.immunoinformaticsjournal.com/article/S2667-1190(25)00004-7/fulltext

Research Article Volume 18 100050 June 2025 Open access
Molecular mimicry impact of the COVID-19 pandemic: Sequence homology between SARS-CoV-2 and autoimmune diseases epitopes
Pablo Maldonado-Catala
Ram Gouripeddi
Naomi Schlesinger
Julio C. Facelli julio.facelli@utah.edu

aDepartment of Biomedical Informatics and Utah Clinical and Translational Science Institute, The University of Utah, United States

bDivision of Rheumatology, The University of Utah, United States

Abstract

Molecular mimicry is one mechanism by which an infectious agent may trigger an autoimmune disease in a human subject and occurs when foreign- and self-peptides contain similar epitopes that activate an autoimmune response in a susceptible individual.

Here, we employ a scalable in-silico approach, to identify 861 pairs of known SARS-CoV-2 and autoimmune disease epitopes, out of more than one billion possible pairs.

These SARS-CoV-2 epitopes show

1) sequence homology to human autoimmune disorder epitopes,

2) empirical binding data that predict that they bind the same major histocompatibility complex (MHC) molecule

and

3) exhibit high empirical immunogenicity.

Analysis of these epitope pairs reveals an association between autoimmune disorders, such as type 1 diabetes, autoimmune uveitis, ankylosing spondylitis, and SARS-CoV-2 infection.

These associations are consistent with those reported in the literature from the analysis of clinical records.

 

https://www.eurekalert.org/news-releases/1078341

News Release 26-Mar-2025
Research finds potential “molecular mimics” behind COVID-induced autoimmune disease
Peer-Reviewed Publication

University of Utah Health


COVID infection has been linked to higher risk of autoimmune disorders, including rheumatoid arthritis and type 1 diabetes. But why the virus might cause the body’s immune system to go haywire remains unknown, making it difficult to develop therapies to avoid autoimmunity. One hypothesis is that viral “molecular mimics” that resemble the body’s own proteins trigger an immune response against the virus—and healthy tissues get caught in the crossfire.

Now, with advanced data analysis and machine learning, scientists have identified a set of COVID-derived molecular mimics that are most likely to be involved in triggering autoimmunity.

The new results are published in ImmunoInformatics.

The researchers first looked for viral components that are similar to the human proteins known to be attacked in various autoimmune diseases. Theoretically, these viral proteins could trigger the immune system to target the human proteins they resemble. They narrowed down their list of culprits by using machine learning to identify only those viral components that are most likely to be bound by human antibodies.

Some of the viral components the researchers found have been associated with type 1 diabetes or multiple sclerosis.

Importantly, some of the human proteins that the researchers identified as likely targets of COVID-induced autoimmunity are only found in people with specific genetics, suggesting that people who produce those proteins may be at higher risk of COVID-induced autoimmunity.

“It’s exciting that in collaboration with our clinical colleagues, we can now use AI and machine learning to address medical conditions exacerbated by the COVID pandemic,” says Julio Facelli, PhD, distinguished professor of biomedical informatics at University of Utah Health and the senior author on the paper. “Hopefully, our results will lead to better understanding and eventual treatment and prevention of these debilitating conditions.”

###

The results are published in Immunoinformatics as "Molecular mimicry impact of the COVID-19 pandemic: Sequence homology between SARS-CoV-2 and autoimmune diseases epitopes."

Research was supported by the National Library of Medicine (5T15LM007124-24) and by the CTSA award to the Utah Clinical and Translational Science Institute (UM1TR004409). Computational resources were provided by the Utah Center for High Performance Computing. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Journal
ImmunoInformatics

DOI
10.1016/j.immuno.2025.100050

Method of Research
Data/statistical analysis

Subject of Research
Not applicable

Article Title
Molecular mimicry impact of the COVID-19 pandemic: Sequence homology between SARS-CoV-2 and autoimmune diseases epitopes

Article Publication Date
13-Mar-2025

COI Statement
Julio Facelli reports a relationship with the University of Utah that includes: funding grants. Pablo Maldonado reports a relationship with University of Utah that includes: funding grants. Ram Gouripeddi reports a relationship with University of Utah that includes: funding grants. Naomi Schlesinger: Advisor or Review Panel Member: Olatec, AMGEN, Protalix, SOBI, Shanton, Arthrosi, Scilex. None related to this manuscript. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

 

If you look for sequence homologies you will find them everywhere. Ankylosing spondylitis isn't even an autoimmune disease. Sorry, but this is rock bottom stale meme stuff.